No Data
No Data
No Data
No Data
No Data
Odyssey Health, Inc. Strengthens Balance Sheet With $8.7 Million in Net Equity
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medi
AccesswireMar 27 20:30
Oragenics Completes Acquisition of Odyssey Health's Neurological Assets
Oragenics, Inc. (NYSE American: OGEN) announces it has completed its previously announced acquisition of assets related to Odyssey Health, Inc.'s (OTCQB: ODYY) ("Odyssey") proprietary neurological drug therapies and technologies.
OragenicsJan 2 13:00
Odyssey Health Gains Shareholder Approval for Asset Sale With Oragenics
Seeking AlphaDec 12, 2023 22:32
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, ha
AccesswireNov 16, 2023 21:30
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,
AccesswireNov 16, 2023 01:00
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement With Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is p
AccesswireOct 18, 2023 20:30
No Data
No Data